 |
인쇄하기
취소
|
Myungin eye listing on KOSPI in 2009
Myungin Pharm says the firm is filing an application with the Korea Exchange (KRX), the operator of the KOSPI and Kosdaq, for a review of its listing in the first half of next year.
The Financial Supervisory Commission said that the firm should meet all prerequisites, such as financial soundness and stability, to list on the KOSPI.
“Our listing on KOSPI will pave a way for becoming a lar...
The Financial Supervisory Commission said that the firm should meet all prerequisites, such as financial soundness and stability, to list on the KOSPI.
“Our listing on KOSPI will pave a way for becoming a lar...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.